Pfizer loses appeal over co-pay help for $225000 per year heart drug - Endpoints News

The Second Circuit appeals court on Monday sided with the HHS inspector general and confirmed a district court's decision that Pfizer cannot help patients with their co-pays for its $225,000 per year heart drug without violating a federal anti-kickback law. T…

The Sec­ond Cir­cuit ap­peals court on Mon­day sided with the HHS in­spec­tor gen­er­al and con­firmed a dis­trict court’s de­ci­sion that Pfiz­er can­not help pa­tients with their co-pays for its $2… [+2389 chars]

full article...